Metformin-associated lactic acidosis precipitated by zoledronic acid-induced acute kidney injury: A case of polypharmacy in an elderly patient

Clinical Geriatrics

Volumn 19, Issue 2, 2011, Pages 50-52

  Leung, Sharon ^a   LeFrancois, Darlene ^b   Eisen, Lewis A ^a  

^a Division of Critical Care Medicine   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATROPINE; CREATININE; ERGOCALCIFEROL; FUROSEMIDE; GLIMEPIRIDE; INDAPAMIDE; METFORMIN; METOPROLOL; NATEGLINIDE; NITROGEN; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; RISEDRONIC ACID; ROSUVASTATIN; UREA; VANCOMYCIN; ZOLEDRONIC ACID;

ACUTE KIDNEY FAILURE; AGED; ANION GAP; ANTIBIOTIC THERAPY; ANURIA; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRY SKIN; FEMALE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; LABORATORY TEST; LACTIC ACIDOSIS; LEG EDEMA; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; OSTEOPOROSIS; OXYGEN TENSION; POLYPHARMACY; PROTEINURIA; STIMULUS RESPONSE; UREA NITROGEN BLOOD LEVEL;

EID: 79951915121     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Diel IJ, Bergner R, Grötz KA. Adverse effects of bisphosphonates: Current issues. J Support Oncol 2007;5(10):475-482.
2. Perazella MA, Markowitz GS. Bisphosphonate nephrotoxicity. Kidney Int 2008; 74(11):1385-1393.
3. Bodmer M, Amico P, Mihatsch MJ, et al. Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrol Dial Transplant 2007;22(8):2366-2370. (Pubitemid 47244720)
4. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006;17(6):897-907. (Pubitemid 43785797)
5. Black DM, Delmas PD, Eastell R, et al; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007; 356(18):1809-1822. (Pubitemid 46698462)
6. Boonen S, Sellmeyer DE, Lippuner K, et al. Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women. Kidney Int 2008;74(5):641-648.
7. Top 200 generic drugs by units in 2006. Drug Topics. http://drugtopics. modern medicine.com/drugtopics/data/articlestandard//drugtopics/092007/407652/ article.pdf. Accessed December 15, 2010.
8. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22(6):925-927. (Pubitemid 29241046)
9. Bruijstens LA, van Luin M, Buscher-Jungerhans PM, Bosch FH. Reality of severe metformin- induced lactic acidosis in the absence of chronic renal impairment. Neth J Med 2008;66(5):185-190. (Pubitemid 351771998)
10. Ahmad S, Beckett M. Recovery from pH 6.38: Lactic acidosis complicated by hypothermia. Emerg Med J 2002;19(2):169-171. (Pubitemid 34279626)
11. Schure PJ, de Gooijer A, van Zanten AR. Unexpected survival from severe metforminassociated lactic acidosis. Neth J Med 2003;61(10):331-333. (Pubitemid 39089435)